Fig. 3
From: Guy’s cancer cohort – real world evidence for cancer pathways

Kaplan Meier Plot for Progression Free Survival for patients who received single-agent pembrolizumab for bladder cancer based on their neutrophil to lymphocyte ratio
From: Guy’s cancer cohort – real world evidence for cancer pathways
Kaplan Meier Plot for Progression Free Survival for patients who received single-agent pembrolizumab for bladder cancer based on their neutrophil to lymphocyte ratio